U.S. Top High Growth Tech & AI Stocks - Spotless Financials

Circle Internet Group

Market Cap: US$41.8b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

Mereo BioPharma Group

Market Cap: US$268.7m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

Palantir Technologies

Market Cap: US$373.7b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

Vanda Pharmaceuticals

Market Cap: US$275.2m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Gorilla Technology Group

Market Cap: US$474.6m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

Workday

Market Cap: US$61.2b

Provides enterprise cloud applications in the United States and internationally.

OS Therapies

Market Cap: US$59.5m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

ACADIA Pharmaceuticals

Market Cap: US$4.0b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

RenovoRx

Market Cap: US$45.3m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

Aldeyra Therapeutics

Market Cap: US$298.9m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

Atlassian

Market Cap: US$50.3b

Through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide.

Kiniksa Pharmaceuticals International

Market Cap: US$2.2b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

Sea

Market Cap: US$92.7b

Through its subsidiaries, operates as a consumer internet company in Southeast Asia, Latin America, the rest of Asia, and internationally.

HubSpot

Market Cap: US$27.4b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

SoundHound AI

Market Cap: US$4.1b

Develops independent voice artificial intelligence (AI) solutions that enables businesses across automotive, TV, and IoT, and to customer service industries to deliver high-quality conversational experiences to their customers in the United States, Korea, France, Japan, Germany, and internationally.

Cellebrite DI

Market Cap: US$3.3b

Develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.

Reddit

Market Cap: US$29.6b

Operates a digital community in the United States and internationally.

TuHURA Biosciences

Market Cap: US$115.4m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Krystal Biotech

Market Cap: US$4.4b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Semrush Holdings

Market Cap: US$1.3b

Develops an online visibility management software-as-a-service platform in the United States, the United Kingdom, and internationally.

Anavex Life Sciences

Market Cap: US$965.2m

Operates as a biopharmaceutical company.

Commvault Systems

Market Cap: US$8.4b

Provides a cyber resilience platform for protecting and recovering data and cloud-native applications in the Americas and internationally.

Quoin Pharmaceuticals

Market Cap: US$3.9m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

Vericel

Market Cap: US$1.8b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Vertex Pharmaceuticals

Market Cap: US$117.3b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Trade Desk

Market Cap: US$42.3b

Operates as a technology company in the United States and internationally.

Evaxion

Market Cap: US$16.9m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Protalix BioTherapeutics

Market Cap: US$116.2m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

ServiceNow

Market Cap: US$195.7b

Provides cloud-based solution for digital workflows in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally.

Creative Medical Technology Holdings

Market Cap: US$7.2m

A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.

Glimpse Group

Market Cap: US$31.4m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

Protagonist Therapeutics

Market Cap: US$3.4b

A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.

Aprea Therapeutics

Market Cap: US$9.4m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways.

Pure Storage

Market Cap: US$19.5b

Engages in the provision of data storage and management technologies, products, and services in the United States and internationally.

Arcturus Therapeutics Holdings

Market Cap: US$331.1m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ADMA Biologics

Market Cap: US$4.4b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.